Paper Details

  1. Home
  2. Paper Details

Emerging oral drugs for erectile dysfunction.

Author: BrigantiAlberto, GallinaAndrea, MontorsiFrancesco, RigattiPatrizio, SaloniaAndrea, SuardiNazareno

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review examines recent advances in oral pharmacotherapy for erectile dysfunction (ED), focusing on phosphodiesterase type 5 (PDE5) inhibitors and sublingual apomorphine.
Paper Details　
Original Abstract of the Article :
Erectile dysfunction (ED) is a common medical condition that affects the sexual life of millions of men worldwide. Many drugs are now available for the treatment of ED, with oral pharmacotherapy representing the first-line option for most patients. Sildenafil citrate, an inhibitor of the enzyme phos...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1517/eoed.9.1.179.32954

データ提供：米国国立医学図書館（NLM）

Emerging Oral Drugs for Erectile Dysfunction

Erectile dysfunction (ED) is a common medical condition that can have a significant impact on men's health and well-being. This study reviews recent advances in the development of oral medications for ED, focusing on the efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors and sublingual apomorphine.

Expanding the Horizons of ED Treatment: New Oral Medications

The study highlights the availability of several effective oral medications for ED, including sildenafil citrate, tadalafil, and vardenafil. These medications have demonstrated a favorable efficacy and safety profile, providing a valuable treatment option for men experiencing ED. The study also discusses the use of sublingual apomorphine, a dopamine receptor agonist, as a potential treatment option for certain patients.

Navigating the Desert of Sexual Health: Finding the Right Treatment

The study's findings underscore the importance of individualized treatment approaches for ED. Just as a traveler in the desert must choose the right path to reach their destination, men with ED must work with their healthcare provider to find the most effective and safe treatment option. This study provides valuable insights into the latest advances in oral medications for ED, empowering men to make informed decisions about their treatment.

Dr. Camel's Conclusion

The study's findings offer a hopeful glimpse into the future of ED treatment. The development of effective and well-tolerated oral medications provides a valuable tool for men seeking to address this common condition. As we continue to explore the vast landscape of sexual health research, we can work towards a future where ED is effectively managed, enabling men to experience greater sexual satisfaction and well-being.
Date :
  1. Date Completed 2005-07-21
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

15155143

DOI: Digital Object Identifier

10.1517/eoed.9.1.179.32954

Related Literature

Article Analysis
・Side Effects of apomorphine sublingual
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.